Keyword: Cleveland Clinic
Will Entresto be the megablockbuster that was expected? Early numbers say it isn't so. But Novartis has reason to believe, according to some talk at ESC this week.
Valeant has promised discounts of up to 30% for hospitals on newly pricey heart drugs Isuprel and Nitropress. But so far, most hospitals aren't seeing them.